Literature DB >> 26932221

[Progress in research on obstructive sleep apnea syndrome with hypertension].

Jie Li1, Jing Xie1, Mao Jiang1, Juanjuan Huang1, Tianlun Yang2.   

Abstract

Obstructive sleep apnea syndrome (OSAS) is a complicated chronic disease caused by certain reasons, characterized by obstruction of the upper airway and apnea or hypopnea during sleep, which can be followed by anoxia, snoring and daytime sleepiness. Recent studies have shown that hypertension is closely connected to OSAS. OSAS can lead to hypertension by several possible mechanisms. The diagnosis of OSAS mainly depends on the medical history, sign, polysomnogram (PSG) result and the frequency of apnea and hypopnea. OSAS can be relieved by continuous positive airway pressure (CPAP), oral orthodontic treatment, medicine, change of lifestyles and others. This brief review focuses on the mechanism of hypertension due to OSAS and the diagnosis criteria and treatment of OSAS.

Entities:  

Mesh:

Year:  2016        PMID: 26932221     DOI: 10.11817/j.issn.1672-7347.2016.02.015

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  1 in total

1.  miR-485-5p alleviates obstructive sleep apnea syndrome with hypertension by inhibiting PI3K/AKT signaling pathway via downregulating HIF3A expression.

Authors:  Yan Xu; Tao Hu; Huizhen Ding; Yi Yuan; Rui Chen
Journal:  Sleep Breath       Date:  2022-02-08       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.